市場調查報告書
商品編碼
1372449
心臟假體設備市場 - 按產品(心臟瓣膜、起搏器)、最終用途(醫院、門診手術中心)和預測,2023 - 2032 年Cardiac Prosthetic Devices Market - By Product (Heart Valves, Pacemaker), By End-use (Hospitals, Ambulatory Surgical Centers), & Forecast, 2023 - 2032 |
2023年至2032年,心臟假體器械市場規模將以8.4%的年複合成長率成長。心血管疾病患病率的上升和人口的迅速老化正在對全球心臟干涉產生強勁的需求。微創手術和改進材料等技術進步的激增也提高了心臟假體設備的功效和安全性,進一步推動了產業擴張。例如,2022 年9 月,美敦力(Medtronic) 在美國推出了其最新版本的自膨脹式經導管主動脈瓣置換(TAVR) 系統Evolut (TM) FX TAVR 系統,以提高易用性並為醫生提供更多服務可預測的閥門部署。
此外,醫療保健支出和保險覆蓋範圍的增加也增加了患者獲得心臟假體設備的機會。此外,人們對心臟健康的認知不斷增強以及對更高生活品質的追求將推動業務成長。
市場根據產品、最終用途和地區進行分類。
從產品來看,心臟瓣膜領域的心臟假體器械產業在 2023 年至 2032 年期間將以 8.8% 的年複合成長率成長。瓣膜性心臟病病例的增加正在導致心臟瓣膜修復技術的進步。人口老化的加劇也將推動人們對創新和耐用的心臟瓣膜產品的偏好。
就最終用途而言,到 2032 年,門診手術中心領域的年複合成長率將達到 8.8%。這一成長是由對門診心臟手術的日益偏好所推動的。成本效益、減少住院時間和提高醫療保健可近性等優勢也將增加對門診手術中心作為心臟介入治療首選的需求。
從地區來看,在不斷發展的醫療基礎設施、不斷增加的醫療支出和人口老化的推動下,歐洲心臟假體器材產業到 2032 年將以 8.1% 的年複合成長率成長。此外,心臟健康意識的提高和醫療技術的進步將有利於區域市場的成長。此外,微創手術技術和創新材料等醫療技術的不斷進步正在提高心臟手術的品質和成功率,使心臟假體裝置對歐洲地區的患者更加有效和有吸引力。
Cardiac prosthetic devices market size will grow at 8.4% CAGR from 2023 to 2032. The rising prevalence of cardiovascular diseases and the rapidly aging population is creating a strong demand for cardiac interventions worldwide. The surge in technological advancements, such as minimally invasive procedures and improved materials is also enhancing the efficacy and safety of cardiac prosthetic devices, further driving the industry expansion. For instance, in September 2022, Medtronic unveiled the broader availability of its latest iteration of self-expanding transcatheter aortic valve replacement (TAVR) systems in the U.S., the Evolut™ FX TAVR system to improve ease of use and provide physicians with more predictable valve deployment.
Additionally, the increased healthcare spending and insurance coverage is increasing patient access to cardiac prosthetic devices. Furthermore, the growing awareness of heart health and the pursuit of higher quality of life will fuel the business growth.
The market is categorized based on product, end-use, and region.
Based on product, the cardiac prosthetic devices industry from the heart valves segment will grow at an 8.8% CAGR during 2023-2032. The increasing cases of valvular heart diseases is leading to the technological advancements in heart valve prosthetics. The growing aging population will also drive the preference for innovative and durable heart valve products.
With respect to end-use, the ambulatory surgical centers segment will exhibit an 8.8% CAGR through 2032. The growth is driven by the rising preference for outpatient cardiac procedures. Advantages, such as cost-efficiency, reduced hospitalization time, and increased healthcare accessibility will also contribute to the demand for ambulatory surgical centers as favored choice for cardiac interventions.
Regionally, the Europe cardiac prosthetic devices industry will grow at 8.1% CAGR through 2032, driven by evolving healthcare infrastructure, increasing healthcare expenditure, and the growing aging population. Moreover, the rising awareness of heart health and advancements in medical technologies will favor the regional market growth. In addition, the growing advancements in medical technology, such as minimally invasive surgical techniques and innovative materials, are improving the quality and success of cardiac procedures, making the cardiac prosthetic devices more effective and attractive to patients in the European region.